medroxyprogesterone acetate has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birtwistle, J; Bunce, CM; Davies, NJ; Delgado, J; Drayson, MT; Hayden, RE; Khanim, FL; Pearce, C; Pratt, G; Sant, T | 1 |
| Ciarcia, R; Crispino, L; D'Andrilli, G; de Matteis, A; Florio, S; Giordano, A; Kumar, C; Pacilio, C; Pagnini, U; Vacca, G | 1 |
2 other study(ies) available for medroxyprogesterone acetate and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2.
Topics: Apoptosis; Bezafibrate; CD40 Ligand; Cell Proliferation; Drug Combinations; Drug Synergism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Medroxyprogesterone Acetate; Mitochondrial Proteins; Prostaglandin D2; Reactive Oxygen Species; Signal Transduction; Superoxides; Tumor Cells, Cultured | 2009 |
MPA increases idarubicin-induced apoptosis in chronic lymphatic leukaemia cells via caspase-3.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase Inhibitors; Caspases; Dogs; Drug Synergism; Enzyme Inhibitors; Fluorometry; Idarubicin; Isoenzymes; Leukemia, Lymphocytic, Chronic, B-Cell; Medroxyprogesterone Acetate; Nucleosomes; Propidium; Tumor Cells, Cultured | 2003 |